GSK Plc ADR (GSK) Stock: A Closer Look at the Analyst Ratings
GSK Plc ADR (NYSE: GSK) has a price-to-earnings ratio of 13.55x that is above its average ratio. Additionally, the 36-month beta value for GSK is
GSK Plc ADR (NYSE: GSK) has a price-to-earnings ratio of 13.55x that is above its average ratio. Additionally, the 36-month beta value for GSK is
The stock of GSK Plc ADR (GSK) has seen a -0.86% decrease in the past week, with a -5.99% drop in the past month, and
GSK Plc ADR (NYSE: GSK) has a higher price-to-earnings ratio of 13.77x compared to its average ratio, The 36-month beta value for GSK is at
The price-to-earnings ratio for GSK Plc ADR (NYSE: GSK) is above average at 13.95x, Company’s 36-month beta value is 0.67.Analysts have differing opinions on the
GSK Plc ADR (NYSE: GSK)’s stock price has dropped by -0.09 in relation to previous closing price of 42.83. Nevertheless, the company has seen a
© 2024, Fueled by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.